These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 19152222)

  • 21. Human embryonic stem cell technologies and drug discovery.
    Jensen J; Hyllner J; Björquist P
    J Cell Physiol; 2009 Jun; 219(3):513-9. PubMed ID: 19277978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can human embryonic stem cells contribute to the discovery of safer and more effective drugs?
    Cezar GG
    Curr Opin Chem Biol; 2007 Aug; 11(4):405-9. PubMed ID: 17662644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonic stem (ES) cell-derived cardiomyocytes: a good candidate for cell therapy applications.
    Pal R
    Cell Biol Int; 2009 Mar; 33(3):325-36. PubMed ID: 19121644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells.
    Xu C
    J Mol Cell Cardiol; 2012 Jun; 52(6):1203-12. PubMed ID: 22484618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protocols for cardiac differentiation of embryonic stem cells.
    Pucéat M
    Methods; 2008 Jun; 45(2):168-71. PubMed ID: 18593613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.
    Mandenius CF; Steel D; Noor F; Meyer T; Heinzle E; Asp J; Arain S; Kraushaar U; Bremer S; Class R; Sartipy P
    J Appl Toxicol; 2011 Apr; 31(3):191-205. PubMed ID: 21328588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of 'stemness' and stem cell differentiation by microRNAs.
    Sartipy P; Olsson B; Hyllner J; Synnergren J
    IDrugs; 2009 Aug; 12(8):492-6. PubMed ID: 19629883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening.
    Rana P; Anson B; Engle S; Will Y
    Toxicol Sci; 2012 Nov; 130(1):117-31. PubMed ID: 22843568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Directed differentiation of pluripotent stem cells: from developmental biology to therapeutic applications.
    Irion S; Nostro MC; Kattman SJ; Keller GM
    Cold Spring Harb Symp Quant Biol; 2008; 73():101-10. PubMed ID: 19329573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly enriched cardiomyocytes from human embryonic stem cells.
    Xu XQ; Zweigerdt R; Soo SY; Ngoh ZX; Tham SC; Wang ST; Graichen R; Davidson B; Colman A; Sun W
    Cytotherapy; 2008; 10(4):376-89. PubMed ID: 18574770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of long-term cultured embryoid bodies may enhance cardiomyocyte differentiation by BMP2.
    Kim YY; Ku SY; Jang J; Oh SK; Kim HS; Kim SH; Choi YM; Moon SY
    Yonsei Med J; 2008 Oct; 49(5):819-27. PubMed ID: 18972603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human stem cell-derived cardiomyocytes for pharmacological and toxicological modeling.
    Harding SE
    Ann N Y Acad Sci; 2011 Dec; 1245():48-9. PubMed ID: 22211978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cells: current challenges and future promise.
    Battey JF
    Dev Dyn; 2007 Dec; 236(12):3193-8. PubMed ID: 17584855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization.
    He JQ; Ma Y; Lee Y; Thomson JA; Kamp TJ
    Circ Res; 2003 Jul; 93(1):32-9. PubMed ID: 12791707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.
    Gai H; Leung EL; Costantino PD; Aguila JR; Nguyen DM; Fink LM; Ward DC; Ma Y
    Cell Biol Int; 2009 Nov; 33(11):1184-93. PubMed ID: 19729070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding pluripotency--how embryonic stem cells keep their options open.
    Johnson BV; Shindo N; Rathjen PD; Rathjen J; Keough RA
    Mol Hum Reprod; 2008 Sep; 14(9):513-20. PubMed ID: 18716052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation pathways in human embryonic stem cell-derived cardiomyocytes.
    Lev S; Kehat I; Gepstein L
    Ann N Y Acad Sci; 2005 Jun; 1047():50-65. PubMed ID: 16093484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells.
    Xu XQ; Soo SY; Sun W; Zweigerdt R
    Stem Cells; 2009 Sep; 27(9):2163-74. PubMed ID: 19658189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt3a-induced mesoderm formation and cardiomyogenesis in human embryonic stem cells.
    Tran TH; Wang X; Browne C; Zhang Y; Schinke M; Izumo S; Burcin M
    Stem Cells; 2009 Aug; 27(8):1869-78. PubMed ID: 19544447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiomyocyte differentiation from embryonic and adult stem cells.
    Passier R; Mummery C
    Curr Opin Biotechnol; 2005 Oct; 16(5):498-502. PubMed ID: 16099156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.